
Fenerbahce is heading into a key EuroLeague Round 9 match against ASVEL with a big question mark over one of their main players, Scottie Wilbekin. His availability is uncertain as the team hopes to improve their current 3-5 record and get back on track.
Wilbekin’s potential absence is a concern, especially since he only recently returned from a major knee injury. However, the team has also received some positive news with the return of another player, balancing out the roster challenges as they aim for a much-needed win at home.
🤔 Wilbekin’s Fitness in Doubt
Guard Scottie Wilbekin is experiencing some pain, and the team has listed him as a “game-time decision.” This means the final call on whether he plays will be made just before the match on Thursday. The 32-year-old recently made a comeback after a serious right knee injury (a torn ACL) that sidelined him for a long time. In his five games back, he has been contributing with an average of 9.2 points per game.
👍 Roster Gets a Boost
While Wilbekin’s status is up in the air, Fenerbahce has some good news. Brandon Boston Jr. has returned to team practices after recovering from an ankle sprain he suffered in early October. He has been cleared to play in the upcoming game. On the other hand, Arturs Zagars will remain unavailable as he is still recovering from a hamstring issue.
🏀 Coach Calls for Improvement
Head coach Sarunas Jasikevicius stressed the need for his team to bounce back from recent losses. “We need to perform better than we have so far,” he said. He pointed out that ASVEL is a very athletic and strong rebounding team. According to the coach, the key to winning will be moving the ball effectively and improving both individually and as a team.
🔥 A “Must-Win” Game
Center Armando Bacot shared the team’s sense of urgency, calling the upcoming match a “very important and must-win game.” He added that the team is excited to play in front of their home fans again. “We need to apply the lessons learned from our previous games on the floor to win and get back on our feet,” Bacot stated.





